IRF4 Positivity is a Novel Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma

被引：0
|
作者：
Cakir, F. B. [1 ]
Guler, B. [2 ]
Cay, A. [3 ]
Mirapoglu, S. [3 ]
Turkmen, A. Vehaboglu [4 ]
Aki, H. [5 ]
机构：
[1] Bezmialem Vakif Univ, Pediat Hematol Oncol, Istanbul, Turkey
[2] Bezmialem Vakif Univ, Pathol, Istanbul, Turkey
[3] Bezmialem Vakif Univ, Pediat Surg, Istanbul, Turkey
[4] Bezmialem Vakif Univ, Pediat, Istanbul, Turkey
[5] Istanbul Univ, Pathol, Cerrahpasa Med Fac, Istanbul, Turkey
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-228
引用
收藏
页码：S196 / S196
页数：1
相关论文
共 50 条
  • [41] RUNX3: A New Prognostic Marker in Diffuse Large B-Cell Lymphoma?
    Duncan, Virginia E.
    Varambally, Sooryanarayana
    Peker, Deniz
    LABORATORY INVESTIGATION, 2016, 96 : 342A - 342A
  • [42] RUNX3: A New Prognostic Marker in Diffuse Large B-Cell Lymphoma?
    Duncan, Virginia E.
    Varambally, Sooiyanarayana
    Peker, Deniz
    MODERN PATHOLOGY, 2016, 29 : 342A - 342A
  • [43] Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma
    Weilemann, Andre
    Grau, Michael
    Erdmann, Tabea
    Merkel, Olaf
    Sobhiafshar, Ulduz
    Anagnostopoulos, Ioannis
    Hummel, Michael
    Siegert, Antje
    Hayford, Claudia
    Madle, Hannelore
    Wollert-Wulf, Brigitte
    Fichtner, Iduna
    Doerken, Bernd
    Dirnhofer, Stephan
    Mathas, Stephan
    Janz, Martin
    Emre, N. C. Tolga
    Rosenwald, Andreas
    Ott, German
    Lenz, Peter
    Tzankov, Alexandar
    Lenz, Georg
    BLOOD, 2015, 125 (01) : 124 - 132
  • [44] Lymphocytopenia as a prognostic marker for diffuse large B cell lymphomas
    Talaulikar, Dipti
    Choudhury, Ayesha
    Shadbolt, Bruce
    Brown, Michael
    LEUKEMIA & LYMPHOMA, 2008, 49 (05) : 959 - 964
  • [45] Development and validation of a novel prognostic nomogram for advanced diffuse large B cell lymphoma
    Wan, Mengdi
    Zhang, Wei
    Huang, He
    Fang, Xiaojie
    Chen, Yungchang
    Tian, Ying
    Yao, Yuyi
    Weng, Huawei
    Chen, Zegeng
    Yu, Le
    Tian, Yuke
    Huang, Huageng
    Li, Xudong
    Hong, Huangming
    Lin, Tongyu
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
  • [46] Large B-Cell Lymphoma with IRF4 Rearrangement: A Multicentric Italian Study with Focus on Phenotypic and Cytogenetic Features
    Scarmozzino, Federico
    Pizzi, Marco
    Bongiovanni, Lucia
    Lorenzi, Luisa
    Righi, Simona
    Balzarini, Piera
    Agostinelli, Claudio
    Ponzoni, Maurilio
    Sabattini, Elena
    Tos, Angelo Dei
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1483 - S1484
  • [47] Relapse of large B-cell lymphoma with IRF4 rearrangement associated with SLAM-associated protein deficiency
    Elhodaky, Mostafa
    Gunderman, Lauren M.
    Bachula, Mateusz
    Liu, Guorong
    Reilly, Paige
    Schmidt, Mary L.
    Frederiksen, John Karl
    Lu, Xinyan
    Jennings, Lawrence
    Rossoff, Jenna
    Khanolkar, Aaruni
    Gong, Shunyou
    PEDIATRIC BLOOD & CANCER, 2023, 70 (09)
  • [48] Large B-cell Lymphoma with IRF4 gene rearrangement: A Clinico-pathological Study of 8 cases
    Ramos, Josean
    Aqil, Barina
    Chen, Yi-Hua
    Guzman, Estefany
    Yaseen, Nabeel
    Gao, Juehua
    Chen, Qing
    Swaminathan, Suchitra
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1006 - 1007
  • [49] Large B-cell Lymphoma with IRF4 gene rearrangement: A Clinico-pathological Study of 8 cases
    Rao, Shruti
    Shet, Tanuja
    Gujral, Sumeet
    Jain, Hasmukh
    Narula, Gaurav
    Sengar, Manju
    Epari, Sridhar
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1007 - 1008
  • [50] The Role of Cell-Free DNA as a Prognostic Marker in Diffuse Large B Cell Lymphoma with Hepatitis C
    Ghanem, Samar E.
    Alagizy, Hagar A.
    Elkosy, Salah M.
    Elgendy, Ahmed A.
    Afify, Rania M.
    Basuni, Ashraf A.
    Almahdy, Shimaa K.
    EGYPTIAN JOURNAL OF CHEMISTRY, 2024, 67 (13):
12345